OrACELL™: A Viable Alternative to Connective Tissue Graft
This 24 patient study compared root coverage outcomes between autogenous Connective Tissue Graft (CTG) and decellularized human dermis (OrACELL) in gingival recession. The study concluded that vertical recession (VR) and clinical attachment level (CAL) improved significantly in both the CTG and OrACELL groups from baseline to 6 months post-operatively, with no significant differences between groups. In Miller Class III recession defects, OrACELL provided a viable alternative to CTG. Both treatments supported significant improvements, but with OrACELL the need for palatal surgical site is eliminated which reduces post-operative morbidity and surgical time.